Despite a critical role for Cx43 in BC dormancy within BM, its ubiquitous expression and involvement in key cellular processes such as hematopoietic regulation make this an unlikely druggable target to reverse GJIC (Taniguchi Ishikawa et al, 2012; Martins-Marques et al, 2015). The gene discussed is GJA1; the disease is breast cancer.